Aclaris Therapeutics: History Of Failures, And Recent Acquisition Of A 'Blockbuster Potential' Molecule
Aclaris' stock has dropped nearly 70% since September 2023, reflecting its history of failures and dissipations. Explore more ...
This gold ETF is rising sharply after its longest winning streak since 2020 amid tariff concerns
As of Monday morning, the SPDR Gold Shares ETF has surged 10.7% year to date, widely outperforming the S&P 500's 3.1% gain so far in 2025, according to FactSet data, at last check. The iShares Core ...
Tired of fine lines and wrinkles? Dermatologists say a retinol body lotion can help
Retinol body lotions can help target skin concerns. Dermatologists share the benefits; plus shop expert-approved picks from ...